Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103

Tissue Antigens

Volumn 49, Issue 6, 1997, Pages 564-573

  Selvakumar, A ^a   Steffens, U ^a   Palanisamy, N ^a   Chaganti, R S K ^a   Dupont, B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chromosome 19q13.4; Genomic structure; Killer cell inhibitory receptor; KIR103

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOME 19Q; DNA POLYMORPHISM; EXON; GENOME; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0030958426     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02803.x     Document Type: Article

References (36)

1. Yokoyama WM. Hybrid resistance and the Ly49 family of natural killer cell receptors. J Exp Med 1995: 182: 273-277.
2. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM. Chromosomal location of the Ly-49 (Al. YE1/48) multigene family: genetic association with the NK1.1 antigen. J Immunol 1990: 145: 2353-2358.
3. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997: 155: 53-65.
4. Parham P. NK cells, MHC class I antigens and missing self. Immunol Rev 1997: 155: 5-221.
5. Moretta A, Biassoni R, Boltino C et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997: 155: 105-117.
6. Reyburn H, Mandelboim O, Vales-Gomez M et al. Human NK cells: their ligands, receptors and function. Immunol Rev 1997: 155: 119-125.
7. Valiante NM, Lienert K, Shilling HG, Smits B, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 1997: 155: 155-164.
8. Salter RD, Chan H-W, Tadikamalla R, Lawlor DA. Domain organization and sequence relationship of killer cell inhibitory receptors. Immunol Rev 1997: 155: 175-182.
9. Selvakumar A, Steffens U, Dupont B. Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 1997: 155: 183-196.
10. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995: 268: 405-408.
11. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995: 2: 439-449.
12. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1, a natural killer cell receptor for HLA-B allotypes. J Immunol 1995: 155: 2306-2310.
13. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol 1996: 156: 3098-3101.
14. Selvakumar A, Steffens U, Dupont B. NK cell receptor gene of the KIR family with two Ig domains but highest homology to KIR receptors with three Ig domains. Tissue Antigens 1996: 48: 285-295.
15. Döhring C, Samaridis J, Colonna M. Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 1996: 44: 227-230.
16. Pende D, Biassoni R, Cantoni C et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996: 184: 505-518.
17. Burshtyn DN, Scharenberg AM, Wagtmann N et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996: 4: 77-85.
18. Fry AM, Lanier LL, Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 1996: 184: 295-300.
19. Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996: 184: 93-110.
20. Olcese L, Lang P, Vely F et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996: 156: 4531-4534.
21. Valiante NM, Phillips JH, Lanier LL, Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signaling complex in human natural killer (NK) cells. J Exp Med 1996: 184: 2243-2250.
22. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994: 8: 652-658.
23. Kornbluth J, Flomenberg N, Dupont B. Cell surface phenotype of a cloned line of human natural killer cells. J Immunol 1982: 129: 2831-2837.
24. Azuma M, Cayabyab A, Buck D, Philips JH, Lanier LL. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 1992: 149: 1115-1123.
25. Robertson MJ, Cochran KJ, Cameron C, Le J-M, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996: 24: 406-415.
26. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel designed for the Tenth International Histocompatibility Workshop. In: Dupont B, ed. Immunobiology of HLA. Volume I. Histocompatiblity testing 1987. New York: Springer-Verlag, 1989: 11-19.
27. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-235.
28. Houldsworth J, Mathew S, Rao PH et al. RE1 proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996: 87: 25-29.
29. DeWit TPM, Morton HG, Capel PJA, van de Winkel JGJ. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J Immunol 1995: 155: 1203-1209.
30. Suto Y, Maenaka K, Yabe T et al. Chromosomal localization of the human killer cell class 1 receptor family genes to 19q13.4 by fluorescence in situ hybridization. Genomics 1996: 35: 270-272.
31. Arm JP, Gurish MF, Reynolds DS et al. Molecular cloning of gp49, a cell-surface antigen that is preferentially expressed by mouse mast cell progenitors and is a new member of the immunoglobulin superfamily. J Biol Chem 1991: 266: 15966-15973.
32. Katz HR, Vivier E, Castells MC, McCormick MJ, Chambers JM, Austen KF. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci U S A 1996: 93: 10809-10814.
33. Rojo S, Burshtyn DN, Long EO, Wagtmann N. Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol 1997: 158: 9-12.
34. Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J Immunol 1997: 158: 13-17.
35. Castells MC, Wu X, Arm JP, Austen KF, Katz HR. Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J Biol Chem 1994: 269: 8393-8401.
36. Biassoni R, Cantoni C, Falco M et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996: 183: 645-650.